Clinical Trial Update: Fludarabine and Alemtuzumab or Cyclophosphamide Followed by Peripheral Blood Stem Cell Transplant or Alemtuzumab in Treating Patients With Advanced or Progressive Chronic Lymphocytic Leukemia [Phase 2]

View source ↗

Summary

A phase 2 trial evaluating fludarabine with alemtuzumab or cyclophosphamide, followed by peripheral blood stem cell transplantation or alemtuzumab, in advanced …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Alemtuzumab (Alemtuzumab)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Fludarabine (Fludarabine)

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2013-07-30